Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery
Scoliosis; Adolescence
About this trial
This is an interventional treatment trial for Scoliosis; Adolescence focused on measuring scoliosis, acetaminophen
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status 1-3
- patients undergoing spinal fusion surgery
Exclusion Criteria:
- patients who refuse to participate in this study
- patients unable to communicate due to mental impairment or developmental delay
- patients allergic to acetaminophen or its additives or who are contraindicated in acetaminophen administration for other reasons
- patients with existing liver diseases or dysfunction (i.e. active hepatitis, clinically relevant chronic liver conditions, elevated liver enzymes)
- patients who are judged ineligible by the medical staff to participate in the study for other reasons
Sites / Locations
- Asan Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Experimental (Pre): Acetaminophen
Experimental(post): Acetaminophen
Placebo comparator : placebo
Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg after anesthetic induction/before surgical incision and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given at the end of surgery before skin closure.
Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg at the end of surgery before skin closure and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given after anesthetic induction/before surgical incision.
Participants will receive 1.5ml/kg placebo (0.9% saline) before and after surgery and the same dose will be given postoperatively at 8hour intervals for 24hours.